Biogen (BIIB) PT Raised to $314 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $216.65 --0%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 18
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 18
Join SI Premium – FREE
Cantor Fitzgerald analyst Alethia Young raised the price target on Biogen (NASDAQ: BIIB) to $314.00 (from $308.00) while maintaining a Neutral rating.
You May Also Be Interested In
- This biotech stock still Wolfe's top pick as multiple catalysts loomh
- Beacon Lighting Group Ltd (BLX:AU) PT Raised to AUD1.70 at JPMorgan
- JPMorgan Downgrades Huaxia Bank Co Ltd (600015:CH) to Underweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
